Endometriosis-associated recto-sigmoid cancer: a case report

BMC Cancer. 2018 Sep 20;18(1):905. doi: 10.1186/s12885-018-4797-4.

Abstract

Background: Endometriosis is a relatively common condition in women of reproductive age. Malignant transformation of intestinal endometriosis is a very rare event. We report a case in which a patient with a history of endometriosis underwent surgery for malignant intestinal endometriosis.

Case presentation: A 55-year-old woman complained of rectorrhagia and intermittent abdominal pain. A neoplasm was revealed by colonoscopy, CT scan and F18-FDG PET/CT of the recto-sigmoidal colon. The patient underwent a rectal anterior resection, hysterectomy and bilateral salpingo-oophorectomy for treatment. According to the histological and immunohistochemical presentation, the diagnosis of endometriosis-associated recto-sigmoid cancer was confirmed. The patient was treated with adjuvant chemotherapy for 6 months. During the follow-up appointment 22 months later, there was clinical and radiographic evidence of recurrence in the rectum. The patient received chemotherapy again and will receive another surgery after two more cycles of chemotherapy.

Conclusion: We report a case of malignant intestinal endometriosis. Although there is no standard therapy for malignant intestinal endometriosis due to the rarity of this disease, surgery and adjuvant chemotherapy seemed to be rational. This case indicates that local recurrence may be a common situation after standard therapy.

Keywords: Bowel endometriosis; Endometriosis-associated carcinoma; Malignant degeneration.

Publication types

  • Case Reports

MeSH terms

  • Biomarkers, Tumor
  • Biopsy
  • Chemotherapy, Adjuvant
  • Endometriosis / complications*
  • Endometriosis / diagnosis
  • Endometriosis / therapy
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Middle Aged
  • Positron Emission Tomography Computed Tomography
  • Sigmoid Neoplasms / diagnosis*
  • Sigmoid Neoplasms / etiology*
  • Sigmoid Neoplasms / therapy
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Biomarkers, Tumor
  • Fluorodeoxyglucose F18